Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity

Biology of the Neonate

Volumn 88, Issue 3, 2005, Pages 214-227

  Satwani, Prakash ^a   Morris, Erin ^a   Van De Ven, Carmella ^a   Cairo, Mitchell S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adaptive immunity; Cord blood immaturity; Cytokine genes; Immunoregulatory genes; Innate immunity; Neonatal sepsis

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18;

CELLULAR IMMUNITY; DENDRITIC CELL; DNA MICROARRAY; GENE EXPRESSION; HUMAN; IMMUNOREGULATION; MONOCYTE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; UMBILICAL CORD BLOOD;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; INFANT, NEWBORN; KILLER CELLS, NATURAL; LYMPHOKINES; PHAGOCYTES; PHAGOCYTOSIS;

EID: 26444602397     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087585     Document Type: Review

References (102)

1. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
2. Wilson CB: Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986;108:1-12.
3. Cairo MS: Pathophysiology and clinical aspects of neonatal immunology; In Pomerante J, Richardson C (eds): Neonatology for the Clinician. Norwalk, Appleton and Lange, 1993;201-210.
4. Wilson CB, Lewis DB: Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 1990;12(suppl 4):S410-S420.
5. Christensen RD, Rothstein G: Pre- and postnatal development of granulocytic stem cells in the rat. Pediatr Res 1984;18:599-602.
6. Wright WC Jr, Ank BJ, Herbert J, Stiehm ER: Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics 1975;56:579-584.
7. Miller ME: Phagocyte function in the neonate: selected aspects. Pediatrics 1979;64:709-712.
8. Krause PJ, Herson VC, Boutin-Lebowitz J, Eisenfeld L, Block C, LoBello T, Maderazo EG: Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res 1986;20:296-300.
9. Hill HR: Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 1987;22:375-382.
10. Ambruso DR, Bentwood B, Henson PM, Johnston RB Jr: Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res 1984;18:1148-1153.
11. Anderson DC, Pickering LK, Feigin RD: Leukocyte function in normal and infected neonates. J Pediatr 1974;85:420-425.
12. Quie PG, Mills EL: Bactericidal and metabolic function of polymorphonuclear leukocytes. Pediatrics 1979;64:719-721.
13. Cairo MS, van de Ven C, Toy C, Mauss D, Sender L: Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis. Pediatr Res 1989;26:395-399.
14. Cairo MS, Mauss D, Plunkett JM, Gillis S, van de Ven C: Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3. Pediatr Res 1991;29:504-509.
15. Wolach B, Gavrieli R, Pomeranz A: Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions. Pediatr Res 2000;48:369-373.
16. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA: Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 1985;82:1526-1530.
17. Ulich TR, del Castillo J, Souza L: Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am J Pathol 1988;133:630-638.
18. Cairo MS, Gillan ER, Buzby JS, van de Ven C, Suen Y: Circulating steel factor (SLF) and G-CSF levels in preterm and term newborn and adult peripheral blood. Am J Pediatr Hematol Oncol 1993;15:311-315.
19. Cairo MS, Suen Y, Knoppel E, Dana R, Park L, Clark S, van de Ven C, Sender L: Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res 1992;31:574-578.
20. Suen Y, Lee SM, Schreurs J, Knoppel E, Cairo MS: Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered posttranscriptional stability. Blood 1994;84:4269-4277.
21. Chang M, Suen Y, Lee SM, Baly D, Buzby JS, Knoppel E, Wolpe S, Cairo MS: Transforming growth factor-beta 1, macrophage inflammatory protein-1 alpha, and interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood 1994;84:118-124.
22. Cairo MS, Plunkett JM, Mauss D, van de Ven C: Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcus sepsis. Blood 1990;76:1788-1794.
23. Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, deLemos R, Givner L, Nesin M, Wheeler JG, Seth T, van de Ven C, Fanaroff A: A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 1999;134:64-70.
24. Cairo MS, Plunkett JM, Nguyen A, Schendel P, van de Ven C: Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor. Pediatr Res 1993;34:56-61.
25. Cairo MS, Plunkett JM, Nguyen A, van de Ven C: Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis. Blood 1992;80:96-101.
26. Cairo MS, Plunkett JM, Schendel P, van de Ven C: The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count. Exp Hematol 1994;22:1118-1123.
27. Christensen RD, MacFarlane JL, Taylor NL, Hill HR, Rothstein G: Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage and circulating pools. Pediatr Res 1982;16:549-553.
28. Frenck RW, Sarman G, Harper TE, Buescher ES: The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. J Infect Dis 1990;162:109-114.
29. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS: A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 1994;84:1427-1433.
30. Kocherlakota P, La Gamma EF: Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998;102:1107-1111.
31. Miura E, Procianoy RS, Bittar C, Miura CS, Miura MS, Mello C, Christensen RD: A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001;107:30-35.
32. Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Ven C, Worcester C, Agosti JM: Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood 1995;86:2509-2515.
33. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF: The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 1985;134:1508-1515.
34. Morimoto C, Letvin NL, Boyd AW, Hagan M, Brown HM, Kornacki MM, Schlossman SF: The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985;134:3762-3769.
35. Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S: Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988;140:1401-1407.
36. Ledbetter JA, Rose LM, Spooner CE, Beatty PG, Martin PJ, Clark EA: Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J Immunol 1985;135:1819-1825.
37. Seder RA, Gazzinelli R, Sher A, Paul WE: Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-10192.
38. Gazzinelli RT: Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases. Mol Med Today 1996;2:258-267.
39. Munoz AI, Limbert D: Skin reactivity to Candida and streptokinase- streptodornase antigens in normal pediatric subjects: influence of age and acute illness. J Pediatr 1977;91:565-568.
40. Franz ML, Carella JA, Galant SP: Cutaneous delayed hypersensitivity in a healthy pediatric population: diagnostic value of diphtheria-tetanus toxoids. J Pediatr 1976;88:975-977.
41. Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N: Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood. J Immunol 1985;135:2351-2356.
42. Baley JE, Schacter BZ: Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 1985;134:3042-3048.
43. Miyawaki T, Moriya N, Nagaoki T, Taniguchi N: Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood. Immunol Rev 1981;57:61-87.
44. Palacios R, Andersson U: Autologous mixes lymphocyte reaction in human cord blood lymphocytes: decreased generation of helper and cytotoxic T-cell functions and increased proliferative response and induction of suppressor T cells. Cell Immunol 1982;66:88-98.
45. Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, Shenker L, Bard J, Boyse EA: Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992;89:10006-10010.
46. Harris DT, LoCascio J, Besencon FJ: Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant 1994;14:545-553.
47. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE: Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994;154:14-24.
48. Risdon G, Gaddy J, Horie M, Broxmeyer HE: Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA 1995;92:2413-2417.
49. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
50. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
51. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-845.
52. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, et al: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
53. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, et al: Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-4147.
54. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G: Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993;23:1826-1830.
55. Fehniger TA, Caligiuri MA: Interleukin 15: biology and relevance to human disease. Blood 2001;97:14-32.
56. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
57. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
58. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M: Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-4279.
59. Hoshino T, Wiltrout RH, Young HA: IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999;162:5070-5077.
60. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72.
61. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, Gu Y, Su MS, Dinarello CA: Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci USA 1998;95:12550-12555.
62. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin T, Gillespie MT: Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 1998;101:595-603.
63. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K: IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-3973.
64. Krenger W, Ferrara JL: Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 1996;15:50-73.
65. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996;88:945-954.
66. Naume B, Gately M, Espevik T: A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 1992;148:2429-2436.
67. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992;175:779-788.
68. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 1984;160:1147-1169.
69. Phillips JH, Lanier LL: Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 1986;164:814-825.
70. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G: Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 1994;156:480-492.
71. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET: IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 1995;165:33-43.
72. Mehrotra PT, Grant AJ, Siegel JP: Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995;154:5093-5102.
73. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, et al: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264:965-968.
74. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995;154:483-490.
75. Mrozek E, Anderson P, Caligiuri MA: Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996;87:2632-2640.
76. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4935-4939.
77. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994;91:4940-4944.
78. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-1403.
79. Munger W, DeJoy SQ, Jeyaseelan R Sr, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwar SS: Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol 1995;165:289-293.
80. Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY: Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 1995;55:4988-4994.
81. Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997;90:3106-3117.
82. Son YI, Dallal RM, Mailliard RB, Egawa S, Jonak ZL, Lotze MT: Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Res 2001;61:884-888.
83. Nomura A, Takada H, Jin CH, Tanaka T, Ohga S, Hara T: Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response. Exp Hematol 2001;29:1169-1176.
84. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-879.
85. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TA, Bond MW, Moore KW, Sher A, Florentino DF: Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 1991;123:209-229.
86. Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G: IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 1993;151:1938-1949.
87. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995;96:2578-2582.
88. Satwani P, Ayello J, Simpson L, van de Ven C, Cairo MS: Dysregulation of interleukin (IL)-18 gene expression and protein production in basal and activated cord blood (CB) vs. peripheral blood (PB) mononuclear cells and differential effects of IL-18 in CB vs. PB and NK cell immaturity (abstract). Blood 2004;104:727a.
89. Gellin BG, Broome CV, Bibb WF, Weaver RE, Gaventa S, Mascola L: The epidemiology of listeriosis in the United States - 1986. Listeriosis Study Group. Am J Epidemiol 1991;133:392-401.
90. Youdim S, Stutman O, Good RA: Studies of delayed hypersensitivity to L. Monocytogenes in mice: nature of cells involved in passive transfers. Cell Immunol 1973;6:98-109.
91. Suri M, Wu J, Ayello J, van de Ven C, Polin R, Cairo MS: Prophylactic single and sequential cytokines (M-CSF, IL-12, IL-18) in combination with antibiotics (AB) significantly enhances survival during experimental neonatal murine listeriosis: implications for enhancing neonatal immunity (abstract). Pediatr Res 2003;53:309A.
92. Robinson KL, Ayello J, Hughes R, van de Ven C, Issitt L, Kurtzberg J, Cairo MS: Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp Hematol 2002;30:245-251.
93. Ayello J, Satwani P, van de Ven C, O'Neill A, Greenhawt M, Roman E, Baxi L, Simpson L, Cairo MS: Optimal ex vivo expansion (EvE) and activation of natural killer (NK) and NKT cells occur at 7-10 days in recryopreserved and rethawed cord blood (CB): Implications for adoptive cellular immunotherapy post CB transplantation (abstract). Proc Am Assoc Cancer Res 2005;46:1005.
94. Kaminski BA, Kadereit S, Miller RE, Leahy P, Stein KR, Topa DA, Radivoyevitch T, Veigl ML, Laughlin MJ: Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 2003;102:4608-4617.
95. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K: Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999;94:845-852.
96. Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K: Serial analysis of gene expression in human monocytes and macrophages. Blood 1999;94:837-844.
97. Jiang H, van de Ven C, Satwani P, Baxi LV, Cairo MS: Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood. J Immunol 2004;172:5870-5879.
98. Jiang H, van de Ven C, Bradley MB, Satwani P, Baxi L, Cairo MS: Differential expression of genes associated with toll-like receptor-4 (TLR4) signal pathway in lipopolysaccharide (LPS)-induced maturation of cord blood (CB) vs. adult peripheral blood (APB) monocyte (MO)-derived dendritic cells (DC) (abstract). Exp Hematol 2004;32:33.
99. Cairo MS, Suen Y, Knoppel E, van de Ven C, Nguyen A, Sender L: Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults. Pediatr Res 1991;30:362-367.
100. Suen Y, Lee SM, Qian J, van de Ven C, Cairo MS: Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine 1998;16:1369-1377.
101. Buzby JS, Lee SM, Van Winkle P, DeMaria CT, Brewer G, Cairo MS: Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A + U-rich element binding factor. Blood 1996;88:2889-2897.
102. Parravicini E, van de Ven C, Anderson L, and Cairo MS: Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis. Transfus Med Rev 2002;16:11-24.